NICE reconsiders obinutuzumab for CLLDecember 5, 2014Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacy
ASH adds practices to Choosing Wisely listDecember 4, 2014AnemiaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersThrombosisBlood BankingPediatrics
Study shows long-term survival improvements in blood cancersDecember 3, 2014Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple Myeloma
Drug gets orphan designation for MM & CLL/SLLDecember 3, 2014Lymphoma & Plasma Cell DisordersMultiple MyelomaPharmacyNon-Hodgkin Lymphoma
NICE expands use of ESAs in cancer patientsDecember 2, 2014AnemiaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaPharmacy
Mutations indicate predisposition to blood cancersDecember 1, 2014Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple Myeloma
Exposure to hookah smoke may raise risk of blood cancersNovember 24, 2014Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple Myeloma
EZH2 inhibitor is active in NHL with wild-type EZH2November 21, 2014Lymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Potential treatment method induces severe side effectsNovember 19, 2014Lymphoma & Plasma Cell Disorders
Hospice cuts cost and use of care for cancer patientsNovember 12, 2014Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaRelated Issues
Group develops cancer health literacy toolNovember 11, 2014Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaRelated Issues